virus membrane protein, hemagglutinin (HA).10 This work
suggested that phospholipids could be a valuable platform
for pursuing the affinity cleavage of integral membrane
proteins. However, due to the requirement of headgroup
introduction at an early stage of the synthesis, the synthetic
route was not suitable for further derivative preparation.
Chemical cleavage of proteins is a valuable technology
for investigating protein structures,11 protein-protein inter-
actions,12 and also for degrading specific proteins and
abrogating their functions.13 However, such chemical cleav-
age has not yet expanded into the field of integral membrane
protein research, although the methods to investigate the
roles, functions, and structures of integral membrane proteins
still require development.
Scheme 2. Preparation of the Oxyamino-Phospholipids
This background motivated us to develop a general and
convenient method to incorporate a functional group onto a
phospholipid framework for preparing a series of derivatives,
which would be beneficial for screening for more useful
protein cleavable molecules. Here, we report the versatile
synthesis of protein cleavable phospholipids 2, by efficient
introduction of protein cleavable head groups on 1 via oxime
bond formation (oxime ligation)14 at the latter stage of the
synthetic route via the pivotal oxyamino functional group
(Scheme 1). Additionally, we observed that these synthesized
alcohol 4,17 which had a protected oxyamino group,
proceeded smoothly in the presence of 1H-tetrazole, and
successive oxidation of the phosphite intermediate by
TBHP afforded the phosphotriesters 5a and 5b in 85 and
69% yields, respectively.
Removal of the phthalimide group of 5a, by treatment with
methyl hydrazine, yielded the desired O-benzyl-protected
phosphodiester derivative 1a in 91% yield. The same
deprotection reaction afforded the O-cyanoethyl protected
1b without any elimination of the cyanoethyl-protecting
group (Scheme 2). Both of these protected phospholipids 1a
and 1b worked well as key intermediates, in which the benzyl
and cyanoethyl groups could be removed under catalytic
hydrogenation and basic conditions, respectively, after
introduction of the headgroup, via the formation of an oxime
bond as shown in Table 1.
Scheme 1
.
Strategy for Synthesizing Artificial Phospholipids
with Protein Cleavable Head Groups
At first, we tested the introduction of imidazole groups,
which have been used as catalytic centers for peptide bond
hydrolysis18 (Table 1, entries 1 and 2). Oxime bond
formation between 1a and 2-imidazole carboxyaldehyde (6a)
proceeded smoothly in the mixed solvent system of
CHCl3-MeOH to give 7a in 77% yield under neutral
conditions without addition of any additive and/or catalyst
(Table 1, entry 1). The isomeric 4-imidazole moiety was also
incorporated into the cyanoethyl protected 1b in excellent
yield (Table 1, entry 2). The pyrene moiety, which has been
reported to be a protein photocleavable group,19 was also
phospholipids had protein cleavage activities within proteo-
liposomes.
First, phospholipid derivatives containing the oxyamino
headgroup were prepared (Scheme 2). The amidite cou-
pling between the phosphoroamidite 3a15 or 3b16 and the
(10) Furuta, T.; Sakai, M.; Hayashi, H.; Asakawa, T.; Kataoka, F.; Fujii,
S.; Suzuki, T.; Suzuki, Y.; Tanaka, K.; Fishkin, N.; Nakanishi, K. Chem.
Commun. 2005, 4575.
(11) For example, see: Ermacora, M. R.; Ledman, D. W.; Fox, R. O.
Nat. Struct. Biol. 1996, 3, 59.
(12) Datwyler, S. A.; Meares, C. F. Trends Biochem. Sci. 2000, 25, 408.
(13) (a) Jeon, J. W.; Son, S. J.; Yoo, C. E.; Hong, I. S.; Song, J. B.;
Suh, J. Org. Lett. 2002, 4, 4155. (b) Chae, P. S.; Kim, M.; Jeung, C.-S.;
Lee, S. D.; Park, H.; Lee, S.; Suh, J. J. Am. Chem. Soc. 2005, 127, 2396.
(c) Suzuki, A.; Tsumura, K.; Tsuzuki, T.; Matsumura, S.; Toshima, K. Chem.
Commun. 2007, 4260. (d) Suh, J.; Yoo, S. H.; Kim, M. G.; Jeong, K.; Ahn,
J. Y.; Kim, M.; Chae, P. S.; Lee, T. Y.; Lee, J.; Lee, J.; Jang, Y. A.; Ko,
E. H. Angew. Chem., Int. Ed. 2007, 46, 7064.
(16) Xu, Y.; Lee, S. A.; Kutateladze, T. G.; Sbrissa, D.; Shisheva, A.;
Prestwich, G. D. J. Am. Chem. Soc. 2006, 128, 885.
(17) Wey, S.-J.; Augustyniak, M. E.; Cochran, E. D.; Ellis, J. L.; Fang,
X.; Garvey, D. S.; Janero, D. R.; Letts, L. G.; Martino, A. M.; Melim,
T. L.; Murty, M. G.; Richardson, S. K.; Schroeder, J. D.; Selig, W. M.;
Trocha, A. M.; Wexler, R. S.; Young, D. V.; Zemtseva, I. S.; Zifcak, B. M.
J. Med. Chem. 2007, 50, 6367.
(18) Suh, J.; Oh, S. J. Org. Chem. 2000, 65, 7534.
(14) The oxime bond formation (oxime ligation) has been used to
conjugate functional groups, such as fluorescent label, to biomolecules. See
the following reference and references cited therein: Dirksen, A.; Hackeng,
T. M.; Dawson, P. E. Angew. Chem., Int. Ed. 2006, 45, 7581.
(15) Fukase, K.; Yoshimura, T.; Kotani, S.; Kusumoto, S. Bull. Chem.
Soc. Jpn. 1994, 67, 473.
(19) (a) Kumar, C. V.; Buranaprapuk, A. Angew. Chem., Int. Ed. 1997,
36, 2085. (b) Kumar, C. V.; Buranaprapuk, A.; Opiteck, G. J.; Moyer, M. B.;
Jockusch, S.; Turro, N. J. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 10361.
(c) Kumar, C. V.; Buranaprapuk, A. J. Am. Chem. Soc. 1999, 121, 4262.
(d) Buranaprapuk, A.; Kumar, C. V.; Jockusch, S.; Turro, N. J. Tetrahedron
2000, 56, 7019.
4848
Org. Lett., Vol. 10, No. 21, 2008